ExtendicareTSX:EXE +0.23%81 Net Margin % is 8.76% as of Mar. 2026, which is 183% above its 10-year median of 3.09. GuruFocus rates TSX:EXE with a GF Score™ of 81/100 and a GF Value™ of C$13.93 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Extendicare ranks better than 69.01% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Extendicare's Net Income for the
three
months ended in Mar. 2026 was C$41 Mil. Extendicare's Revenue for the
three
months ended in Mar. 2026 was C$465 Mil. Therefore, Extendicare's net margin for the quarter that ended in Mar. 2026 was 8.76%.
The historical rank and industry rank for Extendicare's Net Margin % or its related term are showing as below:
TSX:EXE'
s Net Margin % Range Over the Past 10 Years
Min: 0.19 Med: 3.09 Max: 6.99
Current: 6.99
TSX:EXE's Net Margin % is ranked better than 69.01% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs TSX:EXE: 6.99
Extendicare (TSX:EXE) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Extendicare Net Margin % Related Terms
Extendicare Net Margin % Historical Data
* Premium members only.
The historical data trend for Extendicare's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Extendicare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's Net Margin % distribution charts can be found below:
* The bar in red indicates where Extendicare's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Extendicare (TSX:EXE) has a Net Margin % of 8.76% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Extendicare and its competitors. This is 183% above median its historical median of 3.09. Over the past decade, Extendicare's Net Margin % has ranged from 0.19 to 6.99. According to the industry distribution chart, Extendicare ranks #207 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 31%.
Is Extendicare's Net Margin % too high?
Extendicare's current Net Margin % of 8.76% is 183% above median its 10-year median of 3.09. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 6.99. The Healthcare Providers & Services industry median Net Margin % is 2.89. Extendicare's value of 8.76% is 203.6% above this industry median. Based on the distribution chart, Extendicare ranks #207 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Extendicare has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #207 out of 668 companies for Net Margin %. This puts Extendicare in the upper half of its industry. The industry median Net Margin % is 2.89. Extendicare's value of 8.76% is 203.6% above this benchmark. Historically, Extendicare's own Net Margin % has ranged from 0.19 to 6.99 over the past decade. While the company's 10-year median is 3.09 vs. the industry median of 2.89, Extendicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Extendicare's current Net Margin % of 8.76% is 203.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Extendicare and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Extendicare's current Net Margin % is 8.76%, which is 183% above median its own 10-year median of 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (TSX:EXE) is currently considered Significantly Overvalued. The stock's GF Value™ is C$13.93, compared to a current price of C$34.13 — trading 145% above its estimated fair value. The current Net Margin % is 8.76%, which is 183% above median its 10-year median of 3.09 and 203.6% above the Healthcare Providers & Services industry median of 2.89. Extendicare's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Extendicare (TSX:EXE), the current Net Margin % is 8.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (TSX:EXE) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of C$34.13 is trading 145% above its estimated GF Value™ of C$13.93.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for TSX:EXE:
Net Margin %: 8.76% (183% above median its 10-year median of 3.09)
GF Value™: C$13.93 vs. price of C$34.13 (145% above fair value)
Industry Position: 203.6% above the Healthcare Providers & Services median (#207 of 668)
No single metric tells the full story. See the TSX:EXE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
81GF Score
Get the complete analysis for TSX:EXE
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:EXE has been successfully added to your 
